Ensign Peak Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.5M | Buy |
257,177
+148,481
| +137% | +$13.5M | 0.04% | 288 |
|
|
2025
Q1 | $12.3M | Buy |
108,696
+50,173
| +86% | +$5.68M | 0.02% | 406 |
|
|
2024
Q4 | $6.18M | Buy |
58,523
+4,000
| +7% | +$423K | 0.01% | 593 |
|
|
2024
Q3 | $5.89M | Buy |
54,523
+350
| +0.6% | +$37.8K | 0.01% | 583 |
|
|
2024
Q2 | $5.88M | Buy |
54,173
+38,568
| +247% | +$4.19M | 0.01% | 585 |
|
|
2024
Q1 | $2.06M | Sell |
15,605
-1,331
| -8% | -$176K | ﹤0.01% | 914 |
|
|
2023
Q4 | $2.06M | Sell |
16,936
-5,102
| -23% | -$621K | ﹤0.01% | 904 |
|
|
2023
Q3 | $2.47M | Sell |
22,038
-3,115
| -12% | -$350K | 0.01% | 767 |
|
|
2023
Q2 | $3.66M | Buy |
25,153
+5,925
| +31% | +$863K | 0.01% | 677 |
|
|
2023
Q1 | $2.48M | Buy |
19,228
+165
| +0.9% | +$21.3K | 0.01% | 754 |
|
|
2022
Q4 | $2.43M | Buy |
19,063
+622
| +3% | +$79.3K | 0.01% | 752 |
|
|
2022
Q3 | $1.93M | Sell |
18,441
-144,115
| -89% | -$15.1M | ﹤0.01% | 794 |
|
|
2022
Q2 | $17.1M | Buy |
162,556
+143,170
| +739% | +$15M | 0.04% | 291 |
|
|
2022
Q1 | $2.48M | Sell |
19,386
-5,244
| -21% | -$671K | 0.01% | 806 |
|
|
2021
Q4 | $3.04M | Sell |
24,630
-2,158
| -8% | -$266K | 0.01% | 820 |
|
|
2021
Q3 | $3.81M | Buy |
26,788
+238
| +0.9% | +$33.8K | 0.01% | 767 |
|
|
2021
Q2 | $4.15M | Sell |
26,550
-2,622
| -9% | -$409K | 0.01% | 729 |
|
|
2021
Q1 | $4.53M | Sell |
29,172
-3,548
| -11% | -$551K | 0.01% | 671 |
|
|
2020
Q4 | $4.9M | Sell |
32,720
-38,434
| -54% | -$5.75M | 0.01% | 616 |
|
|
2020
Q3 | $9.4M | Buy |
71,154
+3,333
| +5% | +$441K | 0.02% | 453 |
|
|
2020
Q2 | $7.86M | Buy |
67,821
+37,049
| +120% | +$4.29M | 0.02% | 480 |
|
|
2020
Q1 | $3.02M | Sell |
30,772
-3,697
| -11% | -$363K | 0.01% | 662 |
|
|
2019
Q4 | $5.01M | Buy |
+34,469
| New | +$5.01M | 0.01% | 644 |
|